.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Clarification on Nov. 4 Special Report

November 12, 2014

In the November 4 Drug Topics’ Special Report (15 hospitals to be evaluated on insulin-pen safety), the headline and summary seemed to imply that the 15 hospitals had been singled out due to their unsafe practices with insulin pens. This is not the case. The hospitals were selected to participate in the ASHP’s Mentored Quality Improvement Impact Program for Insulin Pen Safety. Drug Topics regrets any misunderstanding.

In the November 4 Drug Topics’ Special Report (15 hospitals to be evaluated on insulin-pen safety), the headline and summary seemed to imply that the 15 hospitals had been singled out due to their unsafe practices with insulin pens. This is not the case. The hospitals were selected to participate in the ASHP’s Mentored Quality Improvement Impact Program for Insulin Pen Safety. Drug Topics regrets any misunderstanding.